NCT04442035

Brief Summary

In this study, we observed the clinical effect of using music therapy of TCM to improve the status of liver depression in patients with postoperative breast cancer patients, Second we want to explore the efficacy and advantages of traditional Chinese medicine in patients with postoperative breast cancer, and to reveal the clinical use of the efficacy and superiority.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 25, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 24, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 3, 2018

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

June 17, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 22, 2020

Completed
Last Updated

June 22, 2020

Status Verified

June 1, 2020

Enrollment Period

12 months

First QC Date

June 17, 2020

Last Update Submit

June 19, 2020

Conditions

Keywords

breast cancermusic therapyQuality of LifeDepression, Anxiety

Outcome Measures

Primary Outcomes (3)

  • Change From Baseline in Self-Rating Anxiety Scale (SAS) score at 3 Months

    The SAS is validated,self-reported table assessing anxiety state over the past 3 month.Possible scores below 50 defined as no anxiety,range 50 to 59 is Mild anxiety,range 60 to 69 is Moderate anxiety , scores above 70 is Severe Anxiety.The higher the score the worse state change=( months 3 score -Baseline score )

    Baseline and months 3

  • Change From Baseline in Self-Rating Depression Scale(SDS) score at 3 Months

    The SDS is validated,self-reported table assessing depression state over the past 3 month.Possible scores below 52 defined as no anxiety,range 53 to 62 is Mild anxiety,range 63 to 72 is Moderate anxiety , scores above 73 is Severe Anxiety.The higher the score the worse state change=( months 3 score -Baseline score )

    Baseline and months 3

  • Change From Baseline in Quality of Life (FACT-B score) at 3 Months

    The FACT-B is validated,self-reported table assessing quality of life over the past 3 month. The scale evaluation breast cancer patient's quality of life for 5 - dimensional such as physiological, social\&family, emotions ; status ; breast cancer additional entries . The higher the score , the better state change=( months 3 score -Baseline score )

    Baseline and months 3

Study Arms (2)

The teatment group

EXPERIMENTAL

5-element misic therapy

Behavioral: 5-element music therapy

The control group

EXPERIMENTAL

health education

Behavioral: 5-element music therapy

Interventions

participants were treated by TCM five-phase music therapy for not less than 30 minutes per day, and group music therapy was performed every three weeks. In addition, the therapeutic schedule is composed of treatment time (1pm-2pm, 9pm-11pm), frequency treatment (two times a day), intervention (10-15 minutes in the afternoon, 30 minutes in the evening) and content (individuals: dialectical selection of music; groups: community singing, every three weeks).

Also known as: health education
The control groupThe teatment group

Eligibility Criteria

Age27 Years - 66 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • the diagnosis of breast cancer in clinical stage (Ⅰ, Ⅱ, Ⅲ) and postoperative breast cancer during one month;
  • All participants had to have clinical depression and stagnation of liver qi;
  • age 27-66;
  • participants are conscious and willing to be followed up during the treatment.

You may not qualify if:

  • Metastasis of breast cancer or serious complications;
  • Patients with major depressive disorder;
  • The past medical history of mental disorders;
  • The primary diseases including liver, kidney, cerebrovascular, cardiovascular and hematopoietic system diseases;
  • Participating in another clinical study or undergoing another intervention;
  • Patients with hearing loss.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangdong Provincial Chinese medicine hospital

Guangzhou, Guangdong, 510000, China

Location

MeSH Terms

Conditions

DepressionAnxiety DisordersBreast Neoplasms

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental DisordersNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Zheng zhuanfang

    Second Clinical College of Guangzhou University of Traditional Chinese Medicine

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 17, 2020

First Posted

June 22, 2020

Study Start

March 25, 2017

Primary Completion

March 24, 2018

Study Completion

June 3, 2018

Last Updated

June 22, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations